AB

Amalgamated Bank Portfolio holdings

AUM $13B
1-Year Return 23.92%
This Quarter Return
+4.36%
1 Year Return
+23.92%
3 Year Return
+105.94%
5 Year Return
+196.1%
10 Year Return
+496.3%
AUM
$12.2B
AUM Growth
+$42.9M
Cap. Flow
-$195M
Cap. Flow %
-1.6%
Top 10 Hldgs %
32.14%
Holding
3,019
New
19
Increased
384
Reduced
1,106
Closed
31

Sector Composition

1 Technology 30.89%
2 Financials 13.55%
3 Consumer Discretionary 11.99%
4 Healthcare 9.94%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
VHI icon
2926
Valhi
VHI
$461M
$2K ﹤0.01%
82
VTSI icon
2927
VirTra
VTSI
$65.7M
$2K ﹤0.01%
366
FBLG icon
2928
FibroBiologics
FBLG
$24.1M
$2K ﹤0.01%
880
KYTX icon
2929
Kyverna Therapeutics
KYTX
$170M
$2K ﹤0.01%
582
CRML icon
2930
Critical Metals Corp
CRML
$573M
$2K ﹤0.01%
253
SKYE icon
2931
Skye Bioscience
SKYE
$124M
$2K ﹤0.01%
596
SVCO
2932
Silvaco Group
SVCO
$163M
$2K ﹤0.01%
207
BIOA
2933
BioAge Labs, Inc. Common Stock
BIOA
$171M
$2K ﹤0.01%
+414
New +$2K
VCSA
2934
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
$2K ﹤0.01%
324
AIRS icon
2935
AirSculpt Technologies
AIRS
$367M
$1K ﹤0.01%
227
AISP
2936
Airship AI Holdings
AISP
$137M
$1K ﹤0.01%
107
AKYA
2937
DELISTED
Akoya BioSciences
AKYA
$1K ﹤0.01%
465
ALXO icon
2938
ALX Oncology
ALXO
$65.3M
$1K ﹤0.01%
897
AMPX icon
2939
Amprius Technologies
AMPX
$889M
$1K ﹤0.01%
181
ARL icon
2940
American Realty Investors
ARL
$256M
$1K ﹤0.01%
54
ATNM icon
2941
Actinium Pharmaceuticals
ATNM
$49.3M
$1K ﹤0.01%
877
JBIO
2942
Jade Biosciences, Inc. Common Stock
JBIO
$254M
$1K ﹤0.01%
10
BAER icon
2943
Bridger Aerospace
BAER
$113M
$1K ﹤0.01%
310
CAMP icon
2944
CAMP4 Therapeutics Corporation Common Stock
CAMP
$30.6M
$1K ﹤0.01%
+235
New +$1K
CBUS icon
2945
Cibus
CBUS
$67.3M
$1K ﹤0.01%
518
DTI icon
2946
Drilling Tools International
DTI
$69.9M
$1K ﹤0.01%
325
ELEV
2947
DELISTED
Elevation Oncology
ELEV
$1K ﹤0.01%
1,805
GALT icon
2948
Galectin Therapeutics
GALT
$295M
$1K ﹤0.01%
705
GMGI icon
2949
Golden Matrix Group
GMGI
$142M
$1K ﹤0.01%
688
IPSC icon
2950
Century Therapeutics
IPSC
$43.6M
$1K ﹤0.01%
706